Nuvation Bio Inc
For the period ended Sep 30, 2024. Filed Nov 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 6, 2024
NUVB$4.20-3.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
(a) Issuer Purchases of Equity Securities
| Period · Total number ofshares (or units)purchased · Average price paid per share(or unit) · Total number ofshares (or units)purchased aspart of publiclyannounced plansor programs · Maximum number(or approximatedollar value) ofshares (or units)that may yet bepurchased underthe plans orprograms | ||
|---|---|---|
| July 2024 · N/A · $ N/A · N/A · N/A | ||
| August 2024 · N/A · $ N/A · N/A · N/A | ||
| September 2024 · N/A · $ N/A · N/A · N/A | ||
| Total | — | $ N/A |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.